APO RESEARCH · REPORT
Hemodialysis and Peritoneal Dialysis
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.
Product & engineering
Understand the product.
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.
Selected research
Market Analysis & Forecast
Global Hemodialysis and Peritoneal Dialysis Market Analysis and Forecast 2026-2032
Market perspective
Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure.
The classification of Hemodialysis and Peritoneal Dialysis includes Service, Device and Consumables, and the proportion of Service in 2019 is about 81.39%.
Hemodialysis and Peritoneal Dialysis sold through in Hospital, Dialysis Center and other. The most of Hemodialysis and Peritoneal Dialysis sold through Dialysis Center, and the market share of that is about 65.29% in 2019.
Read the full market overview
Market competition is intense. Fresenius, DaVita, Baxter, US rental care, B.Braun, Diaverum, etc. are the leaders of the industry.
Production areas mainly include North America, Europe, China and Japan.
North America is the largest consumption place, with a consumption market share nearly 35.08% in 2019. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28.67% in 2019.
Report Includes
This report presents an overview of global market for Hemodialysis and Peritoneal Dialysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Hemodialysis and Peritoneal Dialysis, also provides the revenue of main regions and countries. Of the upcoming market potential for Hemodialysis and Peritoneal Dialysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hemodialysis and Peritoneal Dialysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hemodialysis and Peritoneal Dialysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hemodialysis and Peritoneal Dialysis revenue, projected growth trends, production technology, application and end-user industry.
Hemodialysis and Peritoneal Dialysis Segment by Company
Fresenius
DaVita
Baxter
US rental care
B.Braun
Diaverum
Nipro
Asahi Kasei
Nikkiso
Toray
WEGO
JMS
Medtronic
Rockwell Medical
SWS Hemodialysis Care
Hemodialysis and Peritoneal Dialysis Segment by Type
Service
Device
Consumables
Hemodialysis and Peritoneal Dialysis Segment by Application
Hospital
Dialysis Centers
Other
Hemodialysis and Peritoneal Dialysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemodialysis and Peritoneal Dialysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemodialysis and Peritoneal Dialysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemodialysis and Peritoneal Dialysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Hemodialysis and Peritoneal Dialysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Hemodialysis and Peritoneal Dialysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemodialysis and Peritoneal Dialysis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Service
- Device
- Consumables
Applications
- Hospital
- Dialysis Centers
- Other
Companies covered
- Fresenius
- DaVita
- Baxter
- US rental care
- B.Braun
- Diaverum
- Nipro
- Asahi Kasei
- Nikkiso
- Toray
- WEGO
- JMS
- Medtronic
- Rockwell Medical
- SWS Hemodialysis Care
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Hemodialysis and Peritoneal Dialysis Market by Type
- 1.2.1 Global Hemodialysis and Peritoneal Dialysis Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Service
- 1.2.3 Device
- 1.2.4 Consumables
- 1.3 Hemodialysis and Peritoneal Dialysis Market by Application
- 1.3.1 Global Hemodialysis and Peritoneal Dialysis Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Dialysis Centers
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Hemodialysis and Peritoneal Dialysis Market Dynamics
- 2.1 Hemodialysis and Peritoneal Dialysis Industry Trends
- 2.2 Hemodialysis and Peritoneal Dialysis Industry Drivers
- 2.3 Hemodialysis and Peritoneal Dialysis Industry Opportunities and Challenges
- 2.4 Hemodialysis and Peritoneal Dialysis Industry Restraints
3 Global Growth Perspective
- 3.1 Global Hemodialysis and Peritoneal Dialysis Market Perspective (2021-2032)
- 3.2 Global Hemodialysis and Peritoneal Dialysis Growth Trends by Region
- 3.2.1 Global Hemodialysis and Peritoneal Dialysis Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Hemodialysis and Peritoneal Dialysis Market Size by Region (2021-2026)
- 3.2.3 Global Hemodialysis and Peritoneal Dialysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Hemodialysis and Peritoneal Dialysis Revenue by Players
- 4.1.1 Global Hemodialysis and Peritoneal Dialysis Revenue by Players (2021-2026)
- 4.1.2 Global Hemodialysis and Peritoneal Dialysis Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Hemodialysis and Peritoneal Dialysis Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Hemodialysis and Peritoneal Dialysis Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Hemodialysis and Peritoneal Dialysis Key Players Headquarters & Area Served
- 4.4 Global Hemodialysis and Peritoneal Dialysis Players, Product Type & Application
- 4.5 Global Hemodialysis and Peritoneal Dialysis Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Hemodialysis and Peritoneal Dialysis Market CR5 and HHI
- 4.6.3 2025 Hemodialysis and Peritoneal Dialysis Tier 1, Tier 2, and Tier 3
5 Hemodialysis and Peritoneal Dialysis Market Size by Type
- 5.1 Global Hemodialysis and Peritoneal Dialysis Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 5.3 Global Hemodialysis and Peritoneal Dialysis Revenue Market Share by Type (2021-2032)
6 Hemodialysis and Peritoneal Dialysis Market Size by Application
- 6.1 Global Hemodialysis and Peritoneal Dialysis Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 6.3 Global Hemodialysis and Peritoneal Dialysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Fresenius
- 7.1.1 Fresenius Company Information
- 7.1.2 Fresenius Business Overview
- 7.1.3 Fresenius Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.1.4 Fresenius Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.1.5 Fresenius Recent Developments
- 7.2 DaVita
- 7.2.1 DaVita Company Information
- 7.2.2 DaVita Business Overview
- 7.2.3 DaVita Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.2.4 DaVita Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.2.5 DaVita Recent Developments
- 7.3 Baxter
- 7.3.1 Baxter Company Information
- 7.3.2 Baxter Business Overview
- 7.3.3 Baxter Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.3.4 Baxter Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.3.5 Baxter Recent Developments
- 7.4 US rental care
- 7.4.1 US rental care Company Information
- 7.4.2 US rental care Business Overview
- 7.4.3 US rental care Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.4.4 US rental care Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.4.5 US rental care Recent Developments
- 7.5 B.Braun
- 7.5.1 B.Braun Company Information
- 7.5.2 B.Braun Business Overview
- 7.5.3 B.Braun Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.5.4 B.Braun Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.5.5 B.Braun Recent Developments
- 7.6 Diaverum
- 7.6.1 Diaverum Company Information
- 7.6.2 Diaverum Business Overview
- 7.6.3 Diaverum Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.6.4 Diaverum Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.6.5 Diaverum Recent Developments
- 7.7 Nipro
- 7.7.1 Nipro Company Information
- 7.7.2 Nipro Business Overview
- 7.7.3 Nipro Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.7.4 Nipro Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.7.5 Nipro Recent Developments
- 7.8 Asahi Kasei
- 7.8.1 Asahi Kasei Company Information
- 7.8.2 Asahi Kasei Business Overview
- 7.8.3 Asahi Kasei Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.8.4 Asahi Kasei Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.8.5 Asahi Kasei Recent Developments
- 7.9 Nikkiso
- 7.9.1 Nikkiso Company Information
- 7.9.2 Nikkiso Business Overview
- 7.9.3 Nikkiso Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.9.4 Nikkiso Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.9.5 Nikkiso Recent Developments
- 7.10 Toray
- 7.10.1 Toray Company Information
- 7.10.2 Toray Business Overview
- 7.10.3 Toray Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.10.4 Toray Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.10.5 Toray Recent Developments
- 7.11 WEGO
- 7.11.1 WEGO Company Information
- 7.11.2 WEGO Business Overview
- 7.11.3 WEGO Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.11.4 WEGO Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.11.5 WEGO Recent Developments
- 7.12 JMS
- 7.12.1 JMS Company Information
- 7.12.2 JMS Business Overview
- 7.12.3 JMS Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.12.4 JMS Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.12.5 JMS Recent Developments
- 7.13 Medtronic
- 7.13.1 Medtronic Company Information
- 7.13.2 Medtronic Business Overview
- 7.13.3 Medtronic Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.13.4 Medtronic Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.13.5 Medtronic Recent Developments
- 7.14 Rockwell Medical
- 7.14.1 Rockwell Medical Company Information
- 7.14.2 Rockwell Medical Business Overview
- 7.14.3 Rockwell Medical Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.14.4 Rockwell Medical Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.14.5 Rockwell Medical Recent Developments
- 7.15 SWS Hemodialysis Care
- 7.15.1 SWS Hemodialysis Care Company Information
- 7.15.2 SWS Hemodialysis Care Business Overview
- 7.15.3 SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Revenue and Gross Margin (2021-2026)
- 7.15.4 SWS Hemodialysis Care Hemodialysis and Peritoneal Dialysis Product Portfolio
- 7.15.5 SWS Hemodialysis Care Recent Developments
8 North America
- 8.1 North America Hemodialysis and Peritoneal Dialysis Revenue (2021-2032)
- 8.2 North America Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 8.2.1 North America Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2026)
- 8.2.2 North America Hemodialysis and Peritoneal Dialysis Revenue by Type (2027-2032)
- 8.3 North America Hemodialysis and Peritoneal Dialysis Revenue Share by Type (2021-2032)
- 8.4 North America Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 8.4.1 North America Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2026)
- 8.4.2 North America Hemodialysis and Peritoneal Dialysis Revenue by Application (2027-2032)
- 8.5 North America Hemodialysis and Peritoneal Dialysis Revenue Share by Application (2021-2032)
- 8.6 North America Hemodialysis and Peritoneal Dialysis Revenue by Country
- 8.6.1 North America Hemodialysis and Peritoneal Dialysis Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Hemodialysis and Peritoneal Dialysis Revenue by Country (2021-2026)
- 8.6.3 North America Hemodialysis and Peritoneal Dialysis Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Hemodialysis and Peritoneal Dialysis Revenue (2021-2032)
- 9.2 Europe Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 9.2.1 Europe Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2026)
- 9.2.2 Europe Hemodialysis and Peritoneal Dialysis Revenue by Type (2027-2032)
- 9.3 Europe Hemodialysis and Peritoneal Dialysis Revenue Share by Type (2021-2032)
- 9.4 Europe Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 9.4.1 Europe Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2026)
- 9.4.2 Europe Hemodialysis and Peritoneal Dialysis Revenue by Application (2027-2032)
- 9.5 Europe Hemodialysis and Peritoneal Dialysis Revenue Share by Application (2021-2032)
- 9.6 Europe Hemodialysis and Peritoneal Dialysis Revenue by Country
- 9.6.1 Europe Hemodialysis and Peritoneal Dialysis Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Hemodialysis and Peritoneal Dialysis Revenue by Country (2021-2026)
- 9.6.3 Europe Hemodialysis and Peritoneal Dialysis Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Hemodialysis and Peritoneal Dialysis Revenue (2021-2032)
- 10.2 China Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 10.2.1 China Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2026)
- 10.2.2 China Hemodialysis and Peritoneal Dialysis Revenue by Type (2027-2032)
- 10.3 China Hemodialysis and Peritoneal Dialysis Revenue Share by Type (2021-2032)
- 10.4 China Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 10.4.1 China Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2026)
- 10.4.2 China Hemodialysis and Peritoneal Dialysis Revenue by Application (2027-2032)
- 10.5 China Hemodialysis and Peritoneal Dialysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Hemodialysis and Peritoneal Dialysis Revenue (2021-2032)
- 11.2 Asia Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 11.2.1 Asia Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2026)
- 11.2.2 Asia Hemodialysis and Peritoneal Dialysis Revenue by Type (2027-2032)
- 11.3 Asia Hemodialysis and Peritoneal Dialysis Revenue Share by Type (2021-2032)
- 11.4 Asia Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 11.4.1 Asia Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2026)
- 11.4.2 Asia Hemodialysis and Peritoneal Dialysis Revenue by Application (2027-2032)
- 11.5 Asia Hemodialysis and Peritoneal Dialysis Revenue Share by Application (2021-2032)
- 11.6 Asia Hemodialysis and Peritoneal Dialysis Revenue by Country
- 11.6.1 Asia Hemodialysis and Peritoneal Dialysis Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Hemodialysis and Peritoneal Dialysis Revenue by Country (2021-2026)
- 11.6.3 Asia Hemodialysis and Peritoneal Dialysis Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Hemodialysis and Peritoneal Dialysis Revenue (2021-2032)
- 12.2 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2032)
- 12.2.1 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Type (2021-2026)
- 12.2.2 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Type (2027-2032)
- 12.3 SAMEA Hemodialysis and Peritoneal Dialysis Revenue Share by Type (2021-2032)
- 12.4 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2032)
- 12.4.1 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Application (2021-2026)
- 12.4.2 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Application (2027-2032)
- 12.5 SAMEA Hemodialysis and Peritoneal Dialysis Revenue Share by Application (2021-2032)
- 12.6 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Country
- 12.6.1 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Country (2021-2026)
- 12.6.3 SAMEA Hemodialysis and Peritoneal Dialysis Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst